ID   KAT5_HUMAN              Reviewed;         513 AA.
AC   Q92993; B4E3C7; C9JL99; O95624; Q13430; Q17RW5; Q561W3; Q6GSE8; Q9BWK7;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2003, sequence version 2.
DT   07-APR-2021, entry version 218.
DE   RecName: Full=Histone acetyltransferase KAT5;
DE            EC=2.3.1.48 {ECO:0000269|PubMed:10096020, ECO:0000269|PubMed:12468530, ECO:0000269|PubMed:29040603, ECO:0000269|PubMed:30704899};
DE   AltName: Full=60 kDa Tat-interactive protein;
DE            Short=Tip60 {ECO:0000303|PubMed:10096020, ECO:0000303|PubMed:11416127, ECO:0000303|PubMed:12801643, ECO:0000303|PubMed:29040603};
DE   AltName: Full=Histone acetyltransferase HTATIP;
DE            Short=HIV-1 Tat interactive protein;
DE   AltName: Full=Lysine acetyltransferase 5;
DE   AltName: Full=cPLA(2)-interacting protein;
GN   Name=KAT5; Synonyms=HTATIP, TIP60;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND INTERACTION WITH HIV-1 TAT
RP   (MICROBIAL INFECTION).
RC   TISSUE=Lymphoblast;
RX   PubMed=8607265; DOI=10.1006/viro.1996.0071;
RA   Kamine J., Elangovan B., Subramanian T., Coleman D., Chinnadurai G.;
RT   "Identification of a cellular protein that specifically interacts with the
RT   essential cysteine region of the HIV-1 Tat transactivator.";
RL   Virology 216:357-366(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH PLA2G4A, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Fibroblast, and Placenta;
RX   PubMed=11416127; DOI=10.1128/mcb.21.14.4470-4481.2001;
RA   Sheridan A.M., Force T., Yoon H.J., O'Leary E., Choukroun G., Taheri M.R.,
RA   Bonventre J.V.;
RT   "PLIP, a novel splice variant of Tip60, interacts with group IV cytosolic
RT   phospholipase A(2), induces apoptosis, and potentiates prostaglandin
RT   production.";
RL   Mol. Cell. Biol. 21:4470-4481(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=12801643; DOI=10.1016/s0378-1119(03)00547-x;
RA   Legube G., Trouche D.;
RT   "Identification of a larger form of the histone acetyl transferase Tip60.";
RL   Gene 310:161-168(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cervix, Liver, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 19-35; 150-177 AND 297-307, IDENTIFICATION IN NUA4
RP   COMPLEX, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12963728; DOI=10.1074/jbc.c300389200;
RA   Cai Y., Jin J., Tomomori-Sato C., Sato S., Sorokina I., Parmely T.J.,
RA   Conaway R.C., Conaway J.W.;
RT   "Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-
RT   containing histone acetyltransferase complex.";
RL   J. Biol. Chem. 278:42733-42736(2003).
RN   [10]
RP   CATALYTIC ACTIVITY IN VITRO.
RX   PubMed=10096020; DOI=10.1046/j.1365-2443.1998.00229.x;
RA   Kimura A., Horikoshi M.;
RT   "Tip60 acetylates six lysines of a specific class in core histones in
RT   vitro.";
RL   Genes Cells 3:789-800(1998).
RN   [11]
RP   IDENTIFICATION IN THE NUA4 COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=10966108; DOI=10.1016/s0092-8674(00)00051-9;
RA   Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M.,
RA   Scully R., Qin J., Nakatani Y.;
RT   "Involvement of the TIP60 histone acetylase complex in DNA repair and
RT   apoptosis.";
RL   Cell 102:463-473(2000).
RN   [12]
RP   INTERACTION WITH EDNRA.
RX   PubMed=11262386; DOI=10.1074/jbc.c000909200;
RA   Lee H.-J., Chun M., Kandror K.V.;
RT   "Tip60 and HDAC7 interact with the endothelin receptor a and may be
RT   involved in downstream signaling.";
RL   J. Biol. Chem. 276:16597-16600(2001).
RN   [13]
RP   UBIQUITINATION.
RX   PubMed=11927554; DOI=10.1093/emboj/21.7.1704;
RA   Legube G., Linares L.K., Lemercier C., Scheffner M., Khochbin S.,
RA   Trouche D.;
RT   "Tip60 is targeted to proteasome-mediated degradation by Mdm2 and
RT   accumulates after UV irradiation.";
RL   EMBO J. 21:1704-1712(2002).
RN   [14]
RP   ROLE IN MYC-DEPENDENT TRANSCRIPTION.
RX   PubMed=12776177; DOI=10.1038/sj.embor.embor861;
RA   Frank S.R., Parisi T., Taubert S., Fernandez P., Fuchs M., Chan H.M.,
RA   Livingston D.M., Amati B.;
RT   "MYC recruits the TIP60 histone acetyltransferase complex to chromatin.";
RL   EMBO Rep. 4:575-580(2003).
RN   [15]
RP   PHOSPHORYLATION AT SER-86 AND SER-90, MUTAGENESIS OF SER-86; SER-90;
RP   LEU-254; LEU-257 AND GLY-380, AND CATALYTIC ACTIVITY.
RX   PubMed=12468530; DOI=10.1074/jbc.m211811200;
RA   Lemercier C., Legube G., Caron C., Louwagie M., Garin J., Trouche D.,
RA   Khochbin S.;
RT   "Tip60 acetyltransferase activity is controlled by phosphorylation.";
RL   J. Biol. Chem. 278:4713-4718(2003).
RN   [16]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH HDAC7.
RX   PubMed=12551922; DOI=10.1074/jbc.m210816200;
RA   Xiao H., Chung J., Kao H.-Y., Yang Y.-C.;
RT   "Tip60 is a co-repressor for STAT3.";
RL   J. Biol. Chem. 278:11197-11204(2003).
RN   [17]
RP   REVIEW ON NUA4 COMPLEX.
RX   PubMed=15196461; DOI=10.1016/j.gde.2004.02.009;
RA   Doyon Y., Cote J.;
RT   "The highly conserved and multifunctional NuA4 HAT complex.";
RL   Curr. Opin. Genet. Dev. 14:147-154(2004).
RN   [18]
RP   ROLE IN TP53-DEPENDENT TRANSCRIPTION.
RX   PubMed=15310756; DOI=10.1074/jbc.m407478200;
RA   Legube G., Linares L.K., Tyteca S., Caron C., Scheffner M.,
RA   Chevillard-Briet M., Trouche D.;
RT   "Role of the histone acetyl transferase Tip60 in the p53 pathway.";
RL   J. Biol. Chem. 279:44825-44833(2004).
RN   [19]
RP   INTERACTION WITH JADE1.
RX   PubMed=15502158; DOI=10.1074/jbc.m410487200;
RA   Panchenko M.V., Zhou M.I., Cohen H.T.;
RT   "von Hippel-Lindau partner Jade-1 is a transcriptional co-activator
RT   associated with histone acetyltransferase activity.";
RL   J. Biol. Chem. 279:56032-56041(2004).
RN   [20]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   NUA4 COMPLEX.
RX   PubMed=14966270; DOI=10.1128/mcb.24.5.1884-1896.2004;
RA   Doyon Y., Selleck W., Lane W.S., Tan S., Cote J.;
RT   "Structural and functional conservation of the NuA4 histone
RT   acetyltransferase complex from yeast to humans.";
RL   Mol. Cell. Biol. 24:1884-1896(2004).
RN   [21]
RP   ROLE IN E2F1-DEPENDENT TRANSCRIPTION.
RX   PubMed=15121871; DOI=10.1128/mcb.24.10.4546-4556.2004;
RA   Taubert S., Gorrini C., Frank S.R., Parisi T., Fuchs M., Chan H.M.,
RA   Livingston D.M., Amati B.;
RT   "E2F-dependent histone acetylation and recruitment of the Tip60
RT   acetyltransferase complex to chromatin in late G1.";
RL   Mol. Cell. Biol. 24:4546-4556(2004).
RN   [22]
RP   ROLE IN TP53-DEPENDENT TRANSCRIPTION.
RX   PubMed=15042092; DOI=10.1038/nature02371;
RA   Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A.,
RA   Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B.,
RA   Agami R., Ge W., Cavet G., Linsley P.S., Beijersbergen R.L., Bernards R.;
RT   "A large-scale RNAi screen in human cells identifies new components of the
RT   p53 pathway.";
RL   Nature 428:431-437(2004).
RN   [23]
RP   INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION), AND UBIQUITINATION
RP   (MICROBIAL INFECTION).
RX   PubMed=16001085; DOI=10.1038/sj.emboj.7600734;
RA   Col E., Caron C., Chable-Bessia C., Legube G., Gazzeri S., Komatsu Y.,
RA   Yoshida M., Benkirane M., Trouche D., Khochbin S.;
RT   "HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic
RT   stresses.";
RL   EMBO J. 24:2634-2645(2005).
RN   [24]
RP   INTERACTION WITH ATM, AND FUNCTION.
RX   PubMed=16141325; DOI=10.1073/pnas.0504211102;
RA   Sun Y., Jiang X., Chen S., Fernandes N., Price B.D.;
RT   "A role for the Tip60 histone acetyltransferase in the acetylation and
RT   activation of ATM.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:13182-13187(2005).
RN   [25]
RP   IDENTIFICATION IN A COMPLEX WITH HINT1.
RX   PubMed=16835243; DOI=10.1074/jbc.m513452200;
RA   Weiske J., Huber O.;
RT   "The histidine triad protein Hint1 triggers apoptosis independent of its
RT   enzymatic activity.";
RL   J. Biol. Chem. 281:27356-27366(2006).
RN   [26]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16387653; DOI=10.1016/j.molcel.2005.12.007;
RA   Doyon Y., Cayrou C., Ullah M., Landry A.-J., Cote V., Selleck W.,
RA   Lane W.S., Tan S., Yang X.-J., Cote J.;
RT   "ING tumor suppressor proteins are critical regulators of chromatin
RT   acetylation required for genome expression and perpetuation.";
RL   Mol. Cell 21:51-64(2006).
RN   [27]
RP   FUNCTION, INTERACTION WITH FOXP3, AND SUBCELLULAR LOCATION.
RX   PubMed=17360565; DOI=10.1073/pnas.0700298104;
RA   Li B., Samanta A., Song X., Iacono K.T., Bembas K., Tao R., Basu S.,
RA   Riley J.L., Hancock W.W., Shen Y., Saouaf S.J., Greene M.I.;
RT   "FOXP3 interactions with histone acetyltransferase and class II histone
RT   deacetylases are required for repression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:4571-4576(2007).
RN   [28]
RP   FUNCTION, INTERACTION WITH NR1D2, AND SUBCELLULAR LOCATION.
RX   PubMed=17996965; DOI=10.1016/j.bbamcr.2007.09.004;
RA   Wang J., Liu N., Liu Z., Li Y., Song C., Yuan H., Li Y.Y., Zhao X., Lu H.;
RT   "The orphan nuclear receptor Rev-erbbeta recruits Tip60 and HDAC1 to
RT   regulate apolipoprotein CIII promoter.";
RL   Biochim. Biophys. Acta 1783:224-236(2008).
RN   [29]
RP   INTERACTION WITH TRIM68.
RX   PubMed=18451177; DOI=10.1158/0008-5472.can-07-6059;
RA   Miyajima N., Maruyama S., Bohgaki M., Kano S., Shigemura M., Shinohara N.,
RA   Nonomura K., Hatakeyama S.;
RT   "TRIM68 regulates ligand-dependent transcription of androgen receptor in
RT   prostate cancer cells.";
RL   Cancer Res. 68:3486-3494(2008).
RN   [30]
RP   INTERACTION WITH ATF2 AND CUL3, AND PROTEASOMAL DEGRADATION.
RX   PubMed=18397884; DOI=10.1074/jbc.m802030200;
RA   Bhoumik A., Singha N., O'Connell M.J., Ronai Z.A.;
RT   "Regulation of TIP60 by ATF2 modulates ATM activation.";
RL   J. Biol. Chem. 283:17605-17614(2008).
RN   [31]
RP   SUMOYLATION AT LYS-430 AND LYS-451, MUTAGENESIS OF LYS-430 AND LYS-451,
RP   SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   IDENTIFICATION OF KAT5-UBE2I-SENP6 COMPLEX.
RX   PubMed=17704809; DOI=10.1038/sj.onc.1210710;
RA   Cheng Z., Ke Y., Ding X., Wang F., Wang H., Wang W., Ahmed K., Liu Z.,
RA   Xu Y., Aikhionbare F., Yan H., Liu J., Xue Y., Yu J., Powell M., Liang S.,
RA   Wu Q., Reddy S.E., Hu R., Huang H., Jin C., Yao X.;
RT   "Functional characterization of TIP60 sumoylation in UV-irradiated DNA
RT   damage response.";
RL   Oncogene 27:931-941(2008).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [33]
RP   FUNCTION, AND INTERACTION WITH TRIM24.
RX   PubMed=19909775; DOI=10.1016/j.bbamcr.2009.11.001;
RA   Kikuchi M., Okumura F., Tsukiyama T., Watanabe M., Miyajima N., Tanaka J.,
RA   Imamura M., Hatakeyama S.;
RT   "TRIM24 mediates ligand-dependent activation of androgen receptor and is
RT   repressed by a bromodomain-containing protein, BRD7, in prostate cancer
RT   cells.";
RL   Biochim. Biophys. Acta 1793:1828-1836(2009).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [35]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-52, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [36]
RP   PHOSPHORYLATION AT SER-86 AND SER-90, AND MUTAGENESIS OF SER-86 AND SER-90.
RX   PubMed=22539723; DOI=10.1126/science.1217032;
RA   Lin S.Y., Li T.Y., Liu Q., Zhang C., Li X., Chen Y., Zhang S.M., Lian G.,
RA   Liu Q., Ruan K., Wang Z., Zhang C.S., Chien K.Y., Wu J., Li Q., Han J.,
RA   Lin S.C.;
RT   "GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to
RT   autophagy.";
RL   Science 336:477-481(2012).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86; SER-90 AND SER-199, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [38]
RP   INTERACTION WITH ZBTB49.
RX   PubMed=25245946; DOI=10.1093/nar/gku857;
RA   Jeon B.N., Kim M.K., Yoon J.H., Kim M.Y., An H., Noh H.J., Choi W.I.,
RA   Koh D.I., Hur M.W.;
RT   "Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating
RT   transcription of p21/CDKN1A and RB upon exposure to genotoxic stress.";
RL   Nucleic Acids Res. 42:11447-11461(2014).
RN   [39]
RP   FUNCTION, AND IDENTIFICATION IN THE SWR1-LIKE COMPLEX.
RX   PubMed=24463511; DOI=10.1038/nature12922;
RA   Obri A., Ouararhni K., Papin C., Diebold M.L., Padmanabhan K., Marek M.,
RA   Stoll I., Roy L., Reilly P.T., Mak T.W., Dimitrov S., Romier C.,
RA   Hamiche A.;
RT   "ANP32E is a histone chaperone that removes H2A.Z from chromatin.";
RL   Nature 505:648-653(2014).
RN   [40]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=29040603; DOI=10.1093/jmcb/mjx045;
RA   Bao X., Liu H., Liu X., Ruan K., Zhang Y., Zhang Z., Hu Q., Liu Y.,
RA   Akram S., Zhang J., Gong Q., Wang W., Yuan X., Li J., Zhao L., Dou Z.,
RA   Tian R., Yao X., Wu J., Shi Y.;
RT   "Mitosis-specific acetylation tunes Ran effector binding for chromosome
RT   segregation.";
RL   J. Mol. Cell Biol. 10:18-32(2018).
RN   [41]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, PHOSPHORYLATION AT
RP   SER-86, AND MUTAGENESIS OF SER-86.
RX   PubMed=30704899; DOI=10.1016/j.molcel.2018.12.017;
RA   Cheng X., Ma X., Zhu Q., Song D., Ding X., Li L., Jiang X., Wang X.,
RA   Tian R., Su H., Shen Z., Chen S., Liu T., Gong W., Liu W., Sun Q.;
RT   "Pacer is a mediator of mTORC1 and GSK3-TIP60 signaling in regulation of
RT   autophagosome maturation and lipid metabolism.";
RL   Mol. Cell 73:1-15(2019).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 227-506 IN COMPLEX WITH ACETYL-COA
RP   AND ZINC IONS, AND ACETYLATION AT LYS-327.
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of acetyltransferase domain of human HIV-1 TAT
RT   interacting protein in complex with acetylcoenzyme A.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [43]
RP   STRUCTURE BY NMR OF 5-78.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RUH-073, a pseudo chromo domain from human cDNA.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Catalytic subunit of the NuA4 histone acetyltransferase
CC       complex which is involved in transcriptional activation of select genes
CC       principally by acetylation of nucleosomal histones H4 and H2A
CC       (PubMed:12776177, PubMed:15042092, PubMed:15121871, PubMed:15310756,
CC       PubMed:14966270, PubMed:16387653, PubMed:19909775, PubMed:15196461).
CC       This modification may both alter nucleosome-DNA interactions and
CC       promote interaction of the modified histones with other proteins which
CC       positively regulate transcription (PubMed:12776177, PubMed:15042092,
CC       PubMed:15121871, PubMed:15310756, PubMed:14966270, PubMed:15196461).
CC       This complex may be required for the activation of transcriptional
CC       programs associated with oncogene and proto-oncogene mediated growth
CC       induction, tumor suppressor mediated growth arrest and replicative
CC       senescence, apoptosis, and DNA repair (PubMed:15196461). NuA4 may also
CC       play a direct role in DNA repair when recruited to sites of DNA damage
CC       (PubMed:15196461). Component of a SWR1-like complex that specifically
CC       mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome
CC       (PubMed:24463511). Also acetylates non-histone proteins, such as ATM,
CC       NR1D2, RAN, FOXP3, ULK1 and RUBCNL/Pacer (PubMed:16141325,
CC       PubMed:17360565, PubMed:17996965, PubMed:29040603, PubMed:30704899).
CC       Directly acetylates and activates ATM (PubMed:16141325). Relieves
CC       NR1D2-mediated inhibition of APOC3 expression by acetylating NR1D2
CC       (PubMed:17996965). Promotes FOXP3 acetylation and positively regulates
CC       its transcriptional repressor activity (PubMed:17360565). Acetylates
CC       RAN at 'Lys-134' (PubMed:29040603). Together with GSK3 (GSK3A or
CC       GSK3B), acts as a regulator of autophagy: phosphorylated at Ser-86 by
CC       GSK3 under starvation conditions, leading to activate acetyltransferase
CC       activity and promote acetylation of key autophagy regulators, such as
CC       ULK1 and RUBCNL/Pacer (PubMed:30704899). {ECO:0000269|PubMed:12776177,
CC       ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:15042092,
CC       ECO:0000269|PubMed:15121871, ECO:0000269|PubMed:15310756,
CC       ECO:0000269|PubMed:16141325, ECO:0000269|PubMed:16387653,
CC       ECO:0000269|PubMed:17360565, ECO:0000269|PubMed:17996965,
CC       ECO:0000269|PubMed:19909775, ECO:0000269|PubMed:24463511,
CC       ECO:0000269|PubMed:29040603, ECO:0000269|PubMed:30704899,
CC       ECO:0000303|PubMed:15196461}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[protein]; Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC         Evidence={ECO:0000269|PubMed:10096020, ECO:0000269|PubMed:12468530,
CC         ECO:0000269|PubMed:29040603, ECO:0000269|PubMed:30704899};
CC   -!- ACTIVITY REGULATION: Acetyltransferase activity is promoted by
CC       phosphorylation at Ser-86 by GSK3 (GSK3A or GSK3B).
CC       {ECO:0000269|PubMed:30704899}.
CC   -!- SUBUNIT: Component of the NuA4 histone acetyltransferase complex which
CC       contains the catalytic subunit KAT5/TIP60 and the subunits EP400,
CC       TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2,
CC       ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP,
CC       YEATS4/GAS41, VPS72/YL1 and MEAF6 (PubMed:12963728, PubMed:10966108,
CC       PubMed:15196461, PubMed:14966270). HTATTIP/TIP60, EPC1, and ING3
CC       together constitute a minimal HAT complex termed Piccolo NuA4. The NuA4
CC       complex interacts with MYC. Interacts with ATM (PubMed:16141325).
CC       Interacts with JADE1 (PubMed:15502158). Interacts with PLA2G4A/CPLA2,
CC       EDNRA and HDAC7 (PubMed:11416127, PubMed:11262386, PubMed:12551922).
CC       Interacts with the cytoplasmic tail of APP and APBB1/FE65 (By
CC       similarity). Interacts with TRIM24 and TRIM68 (PubMed:18451177,
CC       PubMed:19909775). Forms a complex with SENP6 and UBE2I in response to
CC       UV irradiation. Identified in a complex with HINT1 (PubMed:16835243).
CC       Interacts with ATF2 and CUL3 (PubMed:18397884). Interacts with NR1D2
CC       (via N-terminus) (PubMed:17996965). Component of a SWR1-like complex
CC       (PubMed:24463511). Interacts with FOXP3 (PubMed:17360565). Interacts
CC       with ZBTB49 (PubMed:25245946). {ECO:0000250|UniProtKB:Q99MK2,
CC       ECO:0000269|PubMed:10966108, ECO:0000269|PubMed:11262386,
CC       ECO:0000269|PubMed:11416127, ECO:0000269|PubMed:12551922,
CC       ECO:0000269|PubMed:12963728, ECO:0000269|PubMed:14966270,
CC       ECO:0000269|PubMed:15502158, ECO:0000269|PubMed:16001085,
CC       ECO:0000269|PubMed:16141325, ECO:0000269|PubMed:16835243,
CC       ECO:0000269|PubMed:17360565, ECO:0000269|PubMed:17996965,
CC       ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:18451177,
CC       ECO:0000269|PubMed:19909775, ECO:0000269|PubMed:24463511,
CC       ECO:0000269|PubMed:25245946, ECO:0000269|Ref.42,
CC       ECO:0000303|PubMed:15196461}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 TAT.
CC       {ECO:0000269|PubMed:16001085, ECO:0000269|PubMed:8607265}.
CC   -!- INTERACTION:
CC       Q92993; P01023: A2M; NbExp=3; IntAct=EBI-399080, EBI-640741;
CC       Q92993; Q15027: ACAP1; NbExp=3; IntAct=EBI-399080, EBI-751746;
CC       Q92993; Q9NPJ3: ACOT13; NbExp=3; IntAct=EBI-399080, EBI-1045357;
CC       Q92993; Q15699: ALX1; NbExp=3; IntAct=EBI-399080, EBI-750671;
CC       Q92993; Q8IWZ3-3: ANKHD1; NbExp=3; IntAct=EBI-399080, EBI-25833200;
CC       Q92993; O00213-2: APBB1; NbExp=3; IntAct=EBI-399080, EBI-13307975;
CC       Q92993; P05067: APP; NbExp=3; IntAct=EBI-399080, EBI-77613;
CC       Q92993; O43307: ARHGEF9; NbExp=3; IntAct=EBI-399080, EBI-3447299;
CC       Q92993; Q66PJ3-4: ARL6IP4; NbExp=3; IntAct=EBI-399080, EBI-5280499;
CC       Q92993; Q9Y576: ASB1; NbExp=3; IntAct=EBI-399080, EBI-2323092;
CC       Q92993; P54253: ATXN1; NbExp=9; IntAct=EBI-399080, EBI-930964;
CC       Q92993; Q96GD4: AURKB; NbExp=4; IntAct=EBI-399080, EBI-624291;
CC       Q92993; Q14032: BAAT; NbExp=3; IntAct=EBI-399080, EBI-8994378;
CC       Q92993; Q9BYV9: BACH2; NbExp=3; IntAct=EBI-399080, EBI-1642333;
CC       Q92993; Q13072: BAGE; NbExp=3; IntAct=EBI-399080, EBI-25884811;
CC       Q92993; Q9H2G9: BLZF1; NbExp=3; IntAct=EBI-399080, EBI-2548012;
CC       Q92993; Q6PH81: C16orf87; NbExp=3; IntAct=EBI-399080, EBI-6598617;
CC       Q92993; Q8NDD1-6: C1orf131; NbExp=3; IntAct=EBI-399080, EBI-17761821;
CC       Q92993; Q6NZI2: CAVIN1; NbExp=3; IntAct=EBI-399080, EBI-2559016;
CC       Q92993; Q9HC52: CBX8; NbExp=2; IntAct=EBI-399080, EBI-712912;
CC       Q92993; Q86Z20: CCDC125; NbExp=3; IntAct=EBI-399080, EBI-11977221;
CC       Q92993; Q96JN2-2: CCDC136; NbExp=3; IntAct=EBI-399080, EBI-10171416;
CC       Q92993; Q96HJ3-2: CCDC34; NbExp=3; IntAct=EBI-399080, EBI-17641690;
CC       Q92993; Q96A33: CCDC47; NbExp=3; IntAct=EBI-399080, EBI-720151;
CC       Q92993; Q9GZT6: CCDC90B; NbExp=3; IntAct=EBI-399080, EBI-713148;
CC       Q92993; Q7Z7K6: CENPV; NbExp=3; IntAct=EBI-399080, EBI-1210604;
CC       Q92993; Q9P2H0: CEP126; NbExp=2; IntAct=EBI-399080, EBI-473176;
CC       Q92993; Q8NHQ1: CEP70; NbExp=3; IntAct=EBI-399080, EBI-739624;
CC       Q92993; Q8TAP6: CEP76; NbExp=3; IntAct=EBI-399080, EBI-742887;
CC       Q92993; Q9NX63: CHCHD3; NbExp=3; IntAct=EBI-399080, EBI-743375;
CC       Q92993; Q99828: CIB1; NbExp=3; IntAct=EBI-399080, EBI-372594;
CC       Q92993; P15169: CPN1; NbExp=3; IntAct=EBI-399080, EBI-2116369;
CC       Q92993; P43234: CTSO; NbExp=3; IntAct=EBI-399080, EBI-2874283;
CC       Q92993; O95424: DEXI; NbExp=3; IntAct=EBI-399080, EBI-724515;
CC       Q92993; O43261: DLEU1; NbExp=2; IntAct=EBI-399080, EBI-710057;
CC       Q92993; Q9NQM4: DNAAF6; NbExp=6; IntAct=EBI-399080, EBI-10239299;
CC       Q92993; P50570-2: DNM2; NbExp=3; IntAct=EBI-399080, EBI-10968534;
CC       Q92993; O43598: DNPH1; NbExp=3; IntAct=EBI-399080, EBI-748674;
CC       Q92993; P21728: DRD1; NbExp=3; IntAct=EBI-399080, EBI-6624459;
CC       Q92993; Q16254: E2F4; NbExp=3; IntAct=EBI-399080, EBI-448943;
CC       Q92993; P20042: EIF2S2; NbExp=3; IntAct=EBI-399080, EBI-711977;
CC       Q92993; P60228: EIF3E; NbExp=3; IntAct=EBI-399080, EBI-347740;
CC       Q92993; Q9H2F5-2: EPC1; NbExp=3; IntAct=EBI-399080, EBI-11023729;
CC       Q92993; Q96J88-3: EPSTI1; NbExp=3; IntAct=EBI-399080, EBI-25885343;
CC       Q92993; P03372-1: ESR1; NbExp=3; IntAct=EBI-399080, EBI-15606245;
CC       Q92993; Q01844: EWSR1; NbExp=2; IntAct=EBI-399080, EBI-739737;
CC       Q92993; Q3B820: FAM161A; NbExp=3; IntAct=EBI-399080, EBI-719941;
CC       Q92993; A0A0C3SFZ9: FCHO1; NbExp=3; IntAct=EBI-399080, EBI-11977403;
CC       Q92993; Q53SE7: FLJ13057; NbExp=3; IntAct=EBI-399080, EBI-10172181;
CC       Q92993; Q9BZS1-1: FOXP3; NbExp=2; IntAct=EBI-399080, EBI-9695448;
CC       Q92993; Q8IVH2-2: FOXP4; NbExp=3; IntAct=EBI-399080, EBI-25885364;
CC       Q92993; Q96NE9-2: FRMD6; NbExp=3; IntAct=EBI-399080, EBI-13213391;
CC       Q92993; O14926: FSCN2; NbExp=3; IntAct=EBI-399080, EBI-21017948;
CC       Q92993; P35637: FUS; NbExp=2; IntAct=EBI-399080, EBI-400434;
CC       Q92993; Q06547-2: GABPB1; NbExp=3; IntAct=EBI-399080, EBI-618189;
CC       Q92993; Q06547-3: GABPB1; NbExp=3; IntAct=EBI-399080, EBI-9088619;
CC       Q92993; O95257: GADD45G; NbExp=2; IntAct=EBI-399080, EBI-448202;
CC       Q92993; P19440-3: GGT1; NbExp=3; IntAct=EBI-399080, EBI-21558069;
CC       Q92993; O75420: GIGYF1; NbExp=3; IntAct=EBI-399080, EBI-947774;
CC       Q92993; Q5VSY0: GKAP1; NbExp=3; IntAct=EBI-399080, EBI-743722;
CC       Q92993; Q96IK5: GMCL1; NbExp=5; IntAct=EBI-399080, EBI-2548508;
CC       Q92993; Q8NEA9: GMCL2; NbExp=3; IntAct=EBI-399080, EBI-745707;
CC       Q92993; O95837: GNA14; NbExp=3; IntAct=EBI-399080, EBI-7951023;
CC       Q92993; Q96F32: GNB5; NbExp=3; IntAct=EBI-399080, EBI-25902214;
CC       Q92993; Q08379: GOLGA2; NbExp=3; IntAct=EBI-399080, EBI-618309;
CC       Q92993; O43292-2: GPAA1; NbExp=3; IntAct=EBI-399080, EBI-25884370;
CC       Q92993; Q9NWQ4-1: GPATCH2L; NbExp=3; IntAct=EBI-399080, EBI-11959863;
CC       Q92993; P29084: GTF2E2; NbExp=3; IntAct=EBI-399080, EBI-2853321;
CC       Q92993; P62805: H4C9; NbExp=4; IntAct=EBI-399080, EBI-302023;
CC       Q92993; O00165: HAX1; NbExp=3; IntAct=EBI-399080, EBI-357001;
CC       Q92993; Q8N7T0: hCG_1820408; NbExp=3; IntAct=EBI-399080, EBI-25858908;
CC       Q92993; Q6NT76: HMBOX1; NbExp=6; IntAct=EBI-399080, EBI-2549423;
CC       Q92993; P52597: HNRNPF; NbExp=3; IntAct=EBI-399080, EBI-352986;
CC       Q92993; Q92826: HOXB13; NbExp=3; IntAct=EBI-399080, EBI-11317274;
CC       Q92993; P09017: HOXC4; NbExp=3; IntAct=EBI-399080, EBI-3923226;
CC       Q92993; Q03933-2: HSF2; NbExp=3; IntAct=EBI-399080, EBI-10223348;
CC       Q92993; O75031: HSF2BP; NbExp=3; IntAct=EBI-399080, EBI-7116203;
CC       Q92993; P42858: HTT; NbExp=15; IntAct=EBI-399080, EBI-466029;
CC       Q92993; Q02363: ID2; NbExp=3; IntAct=EBI-399080, EBI-713450;
CC       Q92993; Q02535: ID3; NbExp=3; IntAct=EBI-399080, EBI-1387094;
CC       Q92993; Q8IY31-3: IFT20; NbExp=3; IntAct=EBI-399080, EBI-9091197;
CC       Q92993; Q96FT9-2: IFT43; NbExp=3; IntAct=EBI-399080, EBI-11944538;
CC       Q92993; P78318: IGBP1; NbExp=3; IntAct=EBI-399080, EBI-1055954;
CC       Q92993; P17936: IGFBP3; NbExp=3; IntAct=EBI-399080, EBI-715709;
CC       Q92993; Q9UKT9: IKZF3; NbExp=6; IntAct=EBI-399080, EBI-747204;
CC       Q92993; P26951: IL3RA; NbExp=3; IntAct=EBI-399080, EBI-1757512;
CC       Q92993; Q8N5Z5: KCTD17; NbExp=3; IntAct=EBI-399080, EBI-743960;
CC       Q92993; Q96MP8-2: KCTD7; NbExp=3; IntAct=EBI-399080, EBI-11954971;
CC       Q92993; Q9Y4X4: KLF12; NbExp=3; IntAct=EBI-399080, EBI-750750;
CC       Q92993; O00505: KPNA3; NbExp=3; IntAct=EBI-399080, EBI-358297;
CC       Q92993; O00629: KPNA4; NbExp=3; IntAct=EBI-399080, EBI-396343;
CC       Q92993; O60684: KPNA6; NbExp=3; IntAct=EBI-399080, EBI-359923;
CC       Q92993; Q5JUW0-3: KRBOX4; NbExp=3; IntAct=EBI-399080, EBI-12893625;
CC       Q92993; Q6A162: KRT40; NbExp=3; IntAct=EBI-399080, EBI-10171697;
CC       Q92993; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-399080, EBI-10172052;
CC       Q92993; Q9BYR8: KRTAP3-1; NbExp=3; IntAct=EBI-399080, EBI-9996449;
CC       Q92993; Q9H2C1: LHX5; NbExp=3; IntAct=EBI-399080, EBI-25835523;
CC       Q92993; Q9Y234: LIPT1; NbExp=3; IntAct=EBI-399080, EBI-727376;
CC       Q92993; Q17RB8: LONRF1; NbExp=3; IntAct=EBI-399080, EBI-2341787;
CC       Q92993; P51884: LUM; NbExp=3; IntAct=EBI-399080, EBI-725780;
CC       Q92993; Q9Y250: LZTS1; NbExp=3; IntAct=EBI-399080, EBI-1216080;
CC       Q92993; Q9BRK4: LZTS2; NbExp=6; IntAct=EBI-399080, EBI-741037;
CC       Q92993; Q96GV9: MACIR; NbExp=3; IntAct=EBI-399080, EBI-2350695;
CC       Q92993; Q9H213: MAGEH1; NbExp=3; IntAct=EBI-399080, EBI-473834;
CC       Q92993; P80192: MAP3K9; NbExp=3; IntAct=EBI-399080, EBI-3951604;
CC       Q92993; Q15759: MAPK11; NbExp=3; IntAct=EBI-399080, EBI-298304;
CC       Q92993; P23508: MCC; NbExp=3; IntAct=EBI-399080, EBI-307531;
CC       Q92993; Q99750: MDFI; NbExp=3; IntAct=EBI-399080, EBI-724076;
CC       Q92993; A0JLT2-2: MED19; NbExp=3; IntAct=EBI-399080, EBI-13288755;
CC       Q92993; P50222: MEOX2; NbExp=3; IntAct=EBI-399080, EBI-748397;
CC       Q92993; Q9H8H3: METTL7A; NbExp=3; IntAct=EBI-399080, EBI-1390168;
CC       Q92993; P41218: MNDA; NbExp=3; IntAct=EBI-399080, EBI-2829677;
CC       Q92993; Q8N983-3: MRPL43; NbExp=3; IntAct=EBI-399080, EBI-11109389;
CC       Q92993; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-399080, EBI-742948;
CC       Q92993; Q5JR59-3: MTUS2; NbExp=4; IntAct=EBI-399080, EBI-11522433;
CC       Q92993; Q16718: NDUFA5; NbExp=3; IntAct=EBI-399080, EBI-746417;
CC       Q92993; P49821: NDUFV1; NbExp=3; IntAct=EBI-399080, EBI-748312;
CC       Q92993; Q9Y2I6: NINL; NbExp=3; IntAct=EBI-399080, EBI-719716;
CC       Q92993; Q9HC29: NOD2; NbExp=2; IntAct=EBI-399080, EBI-7445625;
CC       Q92993; P11926: ODC1; NbExp=6; IntAct=EBI-399080, EBI-1044287;
CC       Q92993; Q2M1J6: OXA1L; NbExp=3; IntAct=EBI-399080, EBI-9978021;
CC       Q92993; Q16342: PDCD2; NbExp=3; IntAct=EBI-399080, EBI-359462;
CC       Q92993; Q9BRX2: PELO; NbExp=3; IntAct=EBI-399080, EBI-1043580;
CC       Q92993; Q8IXK0: PHC2; NbExp=3; IntAct=EBI-399080, EBI-713786;
CC       Q92993; Q9Y6X2: PIAS3; NbExp=3; IntAct=EBI-399080, EBI-2803703;
CC       Q92993; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-399080, EBI-79165;
CC       Q92993; Q86T03: PIP4P1; NbExp=3; IntAct=EBI-399080, EBI-6164623;
CC       Q92993; Q6P1J6-2: PLB1; NbExp=3; IntAct=EBI-399080, EBI-10694821;
CC       Q92993; D3DTS7: PMP22; NbExp=3; IntAct=EBI-399080, EBI-25882629;
CC       Q92993; Q9UNA4: POLI; NbExp=3; IntAct=EBI-399080, EBI-741774;
CC       Q92993; Q96I34: PPP1R16A; NbExp=3; IntAct=EBI-399080, EBI-710402;
CC       Q92993; Q9NQX0: PRDM6; NbExp=3; IntAct=EBI-399080, EBI-11320284;
CC       Q92993; P07225: PROS1; NbExp=3; IntAct=EBI-399080, EBI-2803380;
CC       Q92993; Q86WR7-2: PROSER2; NbExp=3; IntAct=EBI-399080, EBI-13089670;
CC       Q92993; P29074: PTPN4; NbExp=2; IntAct=EBI-399080, EBI-710431;
CC       Q92993; Q3YEC7-3: RABL6; NbExp=3; IntAct=EBI-399080, EBI-25885259;
CC       Q92993; Q96I51: RCC1L; NbExp=3; IntAct=EBI-399080, EBI-2117080;
CC       Q92993; O94844: RHOBTB1; NbExp=3; IntAct=EBI-399080, EBI-6426999;
CC       Q92993; Q9UJD0: RIMS3; NbExp=3; IntAct=EBI-399080, EBI-3909436;
CC       Q92993; Q9NWS8-3: RMND1; NbExp=3; IntAct=EBI-399080, EBI-25884400;
CC       Q92993; Q9Y508: RNF114; NbExp=3; IntAct=EBI-399080, EBI-723587;
CC       Q92993; Q9ULK6-3: RNF150; NbExp=3; IntAct=EBI-399080, EBI-23640835;
CC       Q92993; P62913-2: RPL11; NbExp=3; IntAct=EBI-399080, EBI-11027771;
CC       Q92993; P18077: RPL35A; NbExp=3; IntAct=EBI-399080, EBI-353383;
CC       Q92993; Q9Y265: RUVBL1; NbExp=5; IntAct=EBI-399080, EBI-353675;
CC       Q92993; Q96FV2: SCRN2; NbExp=3; IntAct=EBI-399080, EBI-11306862;
CC       Q92993; Q99643: SDHC; NbExp=3; IntAct=EBI-399080, EBI-1224539;
CC       Q92993; Q14141: SEPTIN6; NbExp=3; IntAct=EBI-399080, EBI-745901;
CC       Q92993; Q14140: SERTAD2; NbExp=3; IntAct=EBI-399080, EBI-2822051;
CC       Q92993; Q01105-2: SET; NbExp=3; IntAct=EBI-399080, EBI-7481343;
CC       Q92993; Q6ZSJ9: SHISA6; NbExp=3; IntAct=EBI-399080, EBI-12037847;
CC       Q92993; Q13573: SNW1; NbExp=3; IntAct=EBI-399080, EBI-632715;
CC       Q92993; Q9Y5X0: SNX10; NbExp=3; IntAct=EBI-399080, EBI-10329478;
CC       Q92993; Q8WV41: SNX33; NbExp=3; IntAct=EBI-399080, EBI-2481535;
CC       Q92993; Q92673: SORL1; NbExp=3; IntAct=EBI-399080, EBI-1171329;
CC       Q92993; P56693: SOX10; NbExp=3; IntAct=EBI-399080, EBI-1167533;
CC       Q92993; P35711: SOX5; NbExp=3; IntAct=EBI-399080, EBI-3505701;
CC       Q92993; Q9UM82: SPATA2; NbExp=3; IntAct=EBI-399080, EBI-744066;
CC       Q92993; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-399080, EBI-5235340;
CC       Q92993; Q01130: SRSF2; NbExp=3; IntAct=EBI-399080, EBI-627047;
CC       Q92993; Q9Y2D8: SSX2IP; NbExp=3; IntAct=EBI-399080, EBI-2212028;
CC       Q92993; Q13586: STIM1; NbExp=3; IntAct=EBI-399080, EBI-448878;
CC       Q92993; Q9NZ72: STMN3; NbExp=3; IntAct=EBI-399080, EBI-725557;
CC       Q92993; Q13033-2: STRN3; NbExp=3; IntAct=EBI-399080, EBI-1053876;
CC       Q92993; O75558: STX11; NbExp=6; IntAct=EBI-399080, EBI-714135;
CC       Q92993; Q8N0S2: SYCE1; NbExp=3; IntAct=EBI-399080, EBI-6872807;
CC       Q92993; O43761: SYNGR3; NbExp=3; IntAct=EBI-399080, EBI-11321949;
CC       Q92993; Q92804: TAF15; NbExp=2; IntAct=EBI-399080, EBI-2255091;
CC       Q92993; Q86VP1: TAX1BP1; NbExp=3; IntAct=EBI-399080, EBI-529518;
CC       Q92993; P15884: TCF4; NbExp=3; IntAct=EBI-399080, EBI-533224;
CC       Q92993; Q92481: TFAP2B; NbExp=3; IntAct=EBI-399080, EBI-725275;
CC       Q92993; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-399080, EBI-1105213;
CC       Q92993; P04183: TK1; NbExp=3; IntAct=EBI-399080, EBI-712550;
CC       Q92993; Q3YBM2: TMEM176B; NbExp=3; IntAct=EBI-399080, EBI-2821479;
CC       Q92993; Q969K7: TMEM54; NbExp=3; IntAct=EBI-399080, EBI-3922833;
CC       Q92993; O14656-2: TOR1A; NbExp=3; IntAct=EBI-399080, EBI-25847109;
CC       Q92993; P04637: TP53; NbExp=3; IntAct=EBI-399080, EBI-366083;
CC       Q92993; P36406: TRIM23; NbExp=3; IntAct=EBI-399080, EBI-740098;
CC       Q92993; P14373: TRIM27; NbExp=3; IntAct=EBI-399080, EBI-719493;
CC       Q92993; O94972: TRIM37; NbExp=3; IntAct=EBI-399080, EBI-741602;
CC       Q92993; Q9UJA5: TRMT6; NbExp=3; IntAct=EBI-399080, EBI-934061;
CC       Q92993; Q99598: TSNAX; NbExp=3; IntAct=EBI-399080, EBI-742638;
CC       Q92993; Q9NNX1: TUFT1; NbExp=3; IntAct=EBI-399080, EBI-2557363;
CC       Q92993; Q15672: TWIST1; NbExp=2; IntAct=EBI-399080, EBI-1797287;
CC       Q92993; Q8TF42: UBASH3B; NbExp=3; IntAct=EBI-399080, EBI-1380492;
CC       Q92993; P62837: UBE2D2; NbExp=3; IntAct=EBI-399080, EBI-347677;
CC       Q92993; Q96BW1: UPRT; NbExp=3; IntAct=EBI-399080, EBI-742943;
CC       Q92993; Q8NB14: USP38; NbExp=3; IntAct=EBI-399080, EBI-2512509;
CC       Q92993; Q15836: VAMP3; NbExp=3; IntAct=EBI-399080, EBI-722343;
CC       Q92993; O95498: VNN2; NbExp=3; IntAct=EBI-399080, EBI-21494555;
CC       Q92993; Q99986: VRK1; NbExp=6; IntAct=EBI-399080, EBI-1769146;
CC       Q92993; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-399080, EBI-12040603;
CC       Q92993; Q9BW85: YJU2; NbExp=3; IntAct=EBI-399080, EBI-10300345;
CC       Q92993; Q9Y2K1: ZBTB1; NbExp=3; IntAct=EBI-399080, EBI-2682961;
CC       Q92993; O43829: ZBTB14; NbExp=3; IntAct=EBI-399080, EBI-10176632;
CC       Q92993; Q8N680: ZBTB2; NbExp=3; IntAct=EBI-399080, EBI-2515601;
CC       Q92993; Q96BR9: ZBTB8A; NbExp=4; IntAct=EBI-399080, EBI-742740;
CC       Q92993; Q53FD0-2: ZC2HC1C; NbExp=6; IntAct=EBI-399080, EBI-14104088;
CC       Q92993; Q9BQ24: ZFYVE21; NbExp=3; IntAct=EBI-399080, EBI-2849569;
CC       Q92993; Q15776: ZKSCAN8; NbExp=3; IntAct=EBI-399080, EBI-2602314;
CC       Q92993; Q14202: ZMYM3; NbExp=3; IntAct=EBI-399080, EBI-2556139;
CC       Q92993; Q05CR2: ZNF248; NbExp=3; IntAct=EBI-399080, EBI-25835471;
CC       Q92993; Q9UL40: ZNF346; NbExp=3; IntAct=EBI-399080, EBI-2462313;
CC       Q92993; Q8TAU3: ZNF417; NbExp=3; IntAct=EBI-399080, EBI-740727;
CC       Q92993; Q8N0Y2-2: ZNF444; NbExp=3; IntAct=EBI-399080, EBI-12010736;
CC       Q92993; Q8NB15: ZNF511; NbExp=3; IntAct=EBI-399080, EBI-10269136;
CC       Q92993; Q8N8E2: ZNF513; NbExp=3; IntAct=EBI-399080, EBI-10279993;
CC       Q92993; Q8TF50: ZNF526; NbExp=3; IntAct=EBI-399080, EBI-11035148;
CC       Q92993; Q9BU19: ZNF692; NbExp=3; IntAct=EBI-399080, EBI-12076976;
CC       Q92993; Q8NAM6: ZSCAN4; NbExp=3; IntAct=EBI-399080, EBI-7252920;
CC       Q92993; O15535: ZSCAN9; NbExp=3; IntAct=EBI-399080, EBI-751531;
CC       Q92993; Q9HBH6; NbExp=3; IntAct=EBI-399080, EBI-25901704;
CC       Q92993; P10085: Myod1; Xeno; NbExp=5; IntAct=EBI-399080, EBI-4405734;
CC       Q92993-2; P01023: A2M; NbExp=3; IntAct=EBI-20795332, EBI-640741;
CC       Q92993-2; P05067: APP; NbExp=3; IntAct=EBI-20795332, EBI-77613;
CC       Q92993-2; P54253: ATXN1; NbExp=3; IntAct=EBI-20795332, EBI-930964;
CC       Q92993-2; P23560-2: BDNF; NbExp=3; IntAct=EBI-20795332, EBI-12275524;
CC       Q92993-2; P0DN79: CBSL; NbExp=3; IntAct=EBI-20795332, EBI-14245939;
CC       Q92993-2; G5E9A7: DMWD; NbExp=3; IntAct=EBI-20795332, EBI-10976677;
CC       Q92993-2; P50570-2: DNM2; NbExp=3; IntAct=EBI-20795332, EBI-10968534;
CC       Q92993-2; P04406: GAPDH; NbExp=3; IntAct=EBI-20795332, EBI-354056;
CC       Q92993-2; P07900: HSP90AA1; NbExp=3; IntAct=EBI-20795332, EBI-296047;
CC       Q92993-2; Q14114-3: LRP8; NbExp=3; IntAct=EBI-20795332, EBI-25832196;
CC       Q92993-2; P51608: MECP2; NbExp=3; IntAct=EBI-20795332, EBI-1189067;
CC       Q92993-2; P00491: PNP; NbExp=3; IntAct=EBI-20795332, EBI-712238;
CC       Q92993-2; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-20795332, EBI-5235340;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17360565}. Nucleus,
CC       nucleolus. Cytoplasm, perinuclear region. Note=Upon stimulation with
CC       EDN1, it is exported from the nucleus to the perinuclear region and UV
CC       irradiation induces translocation into punctuate subnuclear structures
CC       named nuclear bodies.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=2;
CC         IsoId=Q92993-1; Sequence=Displayed;
CC       Name=1; Synonyms=PLIP;
CC         IsoId=Q92993-2; Sequence=VSP_007438;
CC       Name=3;
CC         IsoId=Q92993-3; Sequence=VSP_009104;
CC       Name=4;
CC         IsoId=Q92993-4; Sequence=VSP_009104, VSP_007438;
CC   -!- PTM: (Microbial infection) In case of HIV-1 infection, interaction with
CC       the viral Tat protein leads to KAT5 polyubiquitination and targets it
CC       to degradation. {ECO:0000269|PubMed:16001085}.
CC   -!- PTM: Sumoylated by UBE2I at Lys-430 and Lys-451, leading to increase of
CC       its histone acetyltransferase activity in UV-induced DNA damage
CC       response, as well as its translocation to nuclear bodies.
CC       {ECO:0000269|PubMed:17704809}.
CC   -!- PTM: Ubiquitinated by MDM2, leading to its proteasome-dependent
CC       degradation. {ECO:0000269|PubMed:11927554}.
CC   -!- PTM: Phosphorylated on Ser-86 and Ser-90; enhanced during G2/M phase
CC       (PubMed:12468530). The phosphorylated form has a higher histone
CC       acetyltransferase activity (PubMed:12468530). Phosphorylation at Ser-86
CC       by GSK3 (GSK3A or GSK3B) activates acetyltransferase activity
CC       (PubMed:30704899). Phosphorylation at Ser-90 is a prerequisite for
CC       phosphorylation at Ser-86 by GSK3 (PubMed:30704899).
CC       {ECO:0000269|PubMed:12468530, ECO:0000269|PubMed:30704899}.
CC   -!- PTM: Autoacetylation at Lys-327 is required for proper function.
CC       {ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB02683.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/htatip/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HTATIPID40893ch11q13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U74667; AAB18236.1; -; mRNA.
DR   EMBL; U40989; AAB02683.1; ALT_INIT; mRNA.
DR   EMBL; U67734; AAD00163.1; -; mRNA.
DR   EMBL; AY214165; AAO21130.1; -; Genomic_DNA.
DR   EMBL; AK304664; BAG65439.1; -; mRNA.
DR   EMBL; AP001266; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74427.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74429.1; -; Genomic_DNA.
DR   EMBL; BC000166; AAH00166.3; -; mRNA.
DR   EMBL; BC064912; AAH64912.1; -; mRNA.
DR   EMBL; BC093032; AAH93032.1; -; mRNA.
DR   EMBL; BC143296; AAI43297.1; -; mRNA.
DR   EMBL; BC117167; AAI17168.1; -; mRNA.
DR   CCDS; CCDS31610.1; -. [Q92993-1]
DR   CCDS; CCDS55771.1; -. [Q92993-4]
DR   CCDS; CCDS8109.1; -. [Q92993-2]
DR   CCDS; CCDS8110.1; -. [Q92993-3]
DR   RefSeq; NP_001193762.1; NM_001206833.1. [Q92993-4]
DR   RefSeq; NP_006379.2; NM_006388.3. [Q92993-1]
DR   RefSeq; NP_874368.1; NM_182709.2. [Q92993-2]
DR   RefSeq; NP_874369.1; NM_182710.2. [Q92993-3]
DR   PDB; 2EKO; NMR; -; A=5-78.
DR   PDB; 2OU2; X-ray; 2.30 A; A=227-506.
DR   PDB; 4QQG; X-ray; 2.80 A; A/B/C/D/E/F/G=1-80.
DR   PDBsum; 2EKO; -.
DR   PDBsum; 2OU2; -.
DR   PDBsum; 4QQG; -.
DR   SMR; Q92993; -.
DR   BioGRID; 115779; 288.
DR   ComplexPortal; CPX-709; Piccolo NuA4 histone acetyltransferase complex.
DR   ComplexPortal; CPX-978; NuA4 histone acetyltransferase complex.
DR   CORUM; Q92993; -.
DR   DIP; DIP-5998N; -.
DR   IntAct; Q92993; 307.
DR   MINT; Q92993; -.
DR   STRING; 9606.ENSP00000340330; -.
DR   BindingDB; Q92993; -.
DR   ChEMBL; CHEMBL5750; -.
DR   DrugBank; DB01992; Coenzyme A.
DR   DrugBank; DB02039; S-Acetyl-Cysteine.
DR   GuidetoPHARMACOLOGY; 2664; -.
DR   iPTMnet; Q92993; -.
DR   PhosphoSitePlus; Q92993; -.
DR   BioMuta; KAT5; -.
DR   DMDM; 30923328; -.
DR   CPTAC; CPTAC-2605; -.
DR   CPTAC; CPTAC-2606; -.
DR   EPD; Q92993; -.
DR   jPOST; Q92993; -.
DR   MassIVE; Q92993; -.
DR   MaxQB; Q92993; -.
DR   PaxDb; Q92993; -.
DR   PeptideAtlas; Q92993; -.
DR   PRIDE; Q92993; -.
DR   ProteomicsDB; 75654; -. [Q92993-1]
DR   ProteomicsDB; 75655; -. [Q92993-2]
DR   ProteomicsDB; 75656; -. [Q92993-3]
DR   ProteomicsDB; 75657; -. [Q92993-4]
DR   Antibodypedia; 1823; 717 antibodies.
DR   DNASU; 10524; -.
DR   Ensembl; ENST00000341318; ENSP00000340330; ENSG00000172977. [Q92993-3]
DR   Ensembl; ENST00000352980; ENSP00000344955; ENSG00000172977. [Q92993-2]
DR   Ensembl; ENST00000377046; ENSP00000366245; ENSG00000172977. [Q92993-1]
DR   Ensembl; ENST00000530446; ENSP00000434765; ENSG00000172977. [Q92993-4]
DR   GeneID; 10524; -.
DR   KEGG; hsa:10524; -.
DR   UCSC; uc001ofi.4; human. [Q92993-1]
DR   CTD; 10524; -.
DR   DisGeNET; 10524; -.
DR   GeneCards; KAT5; -.
DR   HGNC; HGNC:5275; KAT5.
DR   HPA; ENSG00000172977; Low tissue specificity.
DR   MIM; 601409; gene.
DR   neXtProt; NX_Q92993; -.
DR   OpenTargets; ENSG00000172977; -.
DR   PharmGKB; PA162392746; -.
DR   VEuPathDB; HostDB:ENSG00000172977.12; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   GeneTree; ENSGT00940000162343; -.
DR   HOGENOM; CLU_011815_2_0_1; -.
DR   InParanoid; Q92993; -.
DR   OMA; SCIYICE; -.
DR   OrthoDB; 629545at2759; -.
DR   PhylomeDB; Q92993; -.
DR   TreeFam; TF317619; -.
DR   PathwayCommons; Q92993; -.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-5685938; HDR through Single Strand Annealing (SSA).
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5693548; Sensing of DNA Double Strand Breaks.
DR   Reactome; R-HSA-5693554; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA).
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693568; Resolution of D-loop Structures through Holliday Junction Intermediates.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693579; Homologous DNA Pairing and Strand Exchange.
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SignaLink; Q92993; -.
DR   SIGNOR; Q92993; -.
DR   BioGRID-ORCS; 10524; 505 hits in 1005 CRISPR screens.
DR   ChiTaRS; KAT5; human.
DR   EvolutionaryTrace; Q92993; -.
DR   GeneWiki; KAT5; -.
DR   GenomeRNAi; 10524; -.
DR   Pharos; Q92993; Tchem.
DR   PRO; PR:Q92993; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q92993; protein.
DR   Bgee; ENSG00000172977; Expressed in testis and 236 other tissues.
DR   ExpressionAtlas; Q92993; baseline and differential.
DR   Genevisible; Q92993; HS.
DR   GO; GO:0035267; C:NuA4 histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0032777; C:Piccolo NuA4 histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0000812; C:Swr1 complex; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription regulator complex; IEA:Ensembl.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061733; F:peptide-lysine-N-acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central.
DR   GO; GO:1904837; P:beta-catenin-TCF complex assembly; TAS:Reactome.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IDA:UniProtKB.
DR   GO; GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:UniProtKB.
DR   GO; GO:0000729; P:DNA double-strand break processing; TAS:Reactome.
DR   GO; GO:0006260; P:DNA replication; TAS:Reactome.
DR   GO; GO:0006302; P:double-strand break repair; IMP:UniProtKB.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
DR   GO; GO:0016573; P:histone acetylation; IDA:UniProtKB.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; IDA:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0018394; P:peptidyl-lysine acetylation; IDA:UniProtKB.
DR   GO; GO:0010508; P:positive regulation of autophagy; IDA:UniProtKB.
DR   GO; GO:1901985; P:positive regulation of protein acetylation; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0040008; P:regulation of growth; IEA:UniProtKB-KW.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0010212; P:response to ionizing radiation; IDA:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.10; -; 1.
DR   IDEAL; IID00492; -.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR016197; Chromo-like_dom_sf.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR037995; KAT5/Tip60.
DR   InterPro; IPR025995; Tudor-knot.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR040706; Zf-MYST.
DR   PANTHER; PTHR10615:SF183; PTHR10615:SF183; 1.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF11717; Tudor-knot; 1.
DR   Pfam; PF17772; zf-MYST; 1.
DR   SMART; SM00298; CHROMO; 1.
DR   SUPFAM; SSF54160; SSF54160; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Acyltransferase;
KW   Alternative splicing; Chromatin regulator; Cytoplasm;
KW   Direct protein sequencing; Growth regulation; Host-virus interaction;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation; Transferase;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..513
FT                   /note="Histone acetyltransferase KAT5"
FT                   /id="PRO_0000051580"
FT   DOMAIN          227..504
FT                   /note="MYST-type HAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   ZN_FING         260..285
FT                   /note="C2HC MYST-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063,
FT                   ECO:0000305|Ref.42"
FT   REGION          368..513
FT                   /note="Interaction with ATF2"
FT                   /evidence="ECO:0000269|PubMed:18397884"
FT   REGION          370..372
FT                   /note="Acetyl-CoA binding"
FT                   /evidence="ECO:0000269|Ref.42"
FT   REGION          377..383
FT                   /note="Acetyl-CoA binding"
FT                   /evidence="ECO:0000269|Ref.42"
FT   ACT_SITE        403
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         407
FT                   /note="Acetyl-CoA"
FT                   /evidence="ECO:0000269|Ref.42"
FT   BINDING         416
FT                   /note="Acetyl-CoA"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   MOD_RES         52
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         86
FT                   /note="Phosphoserine; by GSK3"
FT                   /evidence="ECO:0000269|PubMed:12468530,
FT                   ECO:0000269|PubMed:22539723, ECO:0000269|PubMed:30704899,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         90
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:12468530,
FT                   ECO:0000269|PubMed:22539723, ECO:0007744|PubMed:23186163"
FT   MOD_RES         199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         327
FT                   /note="N6-acetyllysine; by autocatalysis"
FT                   /evidence="ECO:0000269|Ref.42"
FT   CROSSLNK        430
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:17704809"
FT   CROSSLNK        451
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:17704809"
FT   VAR_SEQ         4
FT                   /note="V -> VVSPVPGAGRREPGEVGRARGPPVADPGVALSPQ (in isoform
FT                   3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:12801643,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_009104"
FT   VAR_SEQ         96..147
FT                   /note="Missing (in isoform 1 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11416127,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_007438"
FT   VARIANT         78
FT                   /note="P -> T (in dbSNP:rs11541271)"
FT                   /id="VAR_059456"
FT   MUTAGEN         86
FT                   /note="S->A: Reduced phosphorylation. Abolishes
FT                   phosphorylation; when associated with A-90. Reduced histone
FT                   acetyltransferase activity. Abolished phosphorylation by
FT                   GSK3 and decreased acetyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:12468530,
FT                   ECO:0000269|PubMed:22539723, ECO:0000269|PubMed:30704899"
FT   MUTAGEN         90
FT                   /note="S->A: Reduced phosphorylation. Abolishes
FT                   phosphorylation; when associated with A-86. Reduced histone
FT                   acetyltransferase activity. Abolished phosphorylation by
FT                   GSK3 at S-86."
FT                   /evidence="ECO:0000269|PubMed:12468530,
FT                   ECO:0000269|PubMed:22539723"
FT   MUTAGEN         254
FT                   /note="L->A: Does not affect phosphorylation; when
FT                   associated with A-257."
FT                   /evidence="ECO:0000269|PubMed:12468530"
FT   MUTAGEN         257
FT                   /note="L->A: Does not affect phosphorylation; when
FT                   associated with A-254."
FT                   /evidence="ECO:0000269|PubMed:12468530"
FT   MUTAGEN         380
FT                   /note="G->A: Loss of function. Does not affect
FT                   phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12468530"
FT   MUTAGEN         430
FT                   /note="K->R: Abrogates sumoylation."
FT                   /evidence="ECO:0000269|PubMed:17704809"
FT   MUTAGEN         451
FT                   /note="K->R: Abrogates sumoylation."
FT                   /evidence="ECO:0000269|PubMed:17704809"
FT   CONFLICT        382
FT                   /note="G -> R (in Ref. 1; AAB18236/AAB02683)"
FT                   /evidence="ECO:0000305"
FT   HELIX           4..6
FT                   /evidence="ECO:0007744|PDB:4QQG"
FT   STRAND          12..15
FT                   /evidence="ECO:0007744|PDB:4QQG"
FT   STRAND          28..35
FT                   /evidence="ECO:0007744|PDB:4QQG"
FT   STRAND          37..40
FT                   /evidence="ECO:0007744|PDB:4QQG"
FT   STRAND          42..47
FT                   /evidence="ECO:0007744|PDB:4QQG"
FT   HELIX           52..54
FT                   /evidence="ECO:0007744|PDB:4QQG"
FT   STRAND          56..58
FT                   /evidence="ECO:0007744|PDB:4QQG"
FT   HELIX           60..62
FT                   /evidence="ECO:0007744|PDB:4QQG"
FT   HELIX           65..67
FT                   /evidence="ECO:0007744|PDB:2EKO"
FT   STRAND          235..237
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          240..242
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   HELIX           252..254
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          260..262
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   TURN            264..266
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          269..271
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   HELIX           273..282
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          289..296
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          299..305
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   TURN            306..308
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   HELIX           310..321
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          336..345
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          348..360
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          365..368
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          370..372
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   HELIX           374..376
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   HELIX           381..395
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          400..402
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   HELIX           408..425
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   HELIX           441..448
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   HELIX           452..461
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   STRAND          469..474
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   HELIX           497..499
FT                   /evidence="ECO:0007744|PDB:2OU2"
FT   CONFLICT        Q92993-3:32
FT                   /note="V -> A (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   513 AA;  58582 MW;  63724F5E10B957D5 CRC64;
     MAEVGEIIEG CRLPVLRRNQ DNEDEWPLAE ILSVKDISGR KLFYVHYIDF NKRLDEWVTH
     ERLDLKKIQF PKKEAKTPTK NGLPGSRPGS PEREVPASAQ ASGKTLPIPV QITLRFNLPK
     EREAIPGGEP DQPLSSSSCL QPNHRSTKRK VEVVSPATPV PSETAPASVF PQNGAARRAV
     AAQPGRKRKS NCLGTDEDSQ DSSDGIPSAP RMTGSLVSDR SHDDIVTRMK NIECIELGRH
     RLKPWYFSPY PQELTTLPVL YLCEFCLKYG RSLKCLQRHL TKCDLRHPPG NEIYRKGTIS
     FFEIDGRKNK SYSQNLCLLA KCFLDHKTLY YDTDPFLFYV MTEYDCKGFH IVGYFSKEKE
     STEDYNVACI LTLPPYQRRG YGKLLIEFSY ELSKVEGKTG TPEKPLSDLG LLSYRSYWSQ
     TILEILMGLK SESGERPQIT INEISEITSI KKEDVISTLQ YLNLINYYKG QYILTLSEDI
     VDGHERAMLK RLLRIDSKCL HFTPKDWSKR GKW
//
